Nile Therapeutics, Inc. (NLTX) Earnings
|
Expand Research on NLTX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +16.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/14/23 | Q323 | N/A | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/28/23 | Q223 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/21/23 | Q223 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/16/23 | Q223 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/29/23 | Q123 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/22/23 | Q123 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/10/23 | Q123 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A |
